SUDEEPPHRM₹1,213.50

Sudeep Pharma Ltd.

· Chemicals
₹ CrorePeersSUDARSCHEMSTYRENIXSHARDACROPREFEXRCFRALLISRAINPRIVISCLMcap ₹13,706 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY26
31/03/2026
Last 12M
30/06/2026
Non-current Assets
+ Property, Plant & Equipment224.0224.0
+ Capital Work-in-Progress178.4178.4
+ Goodwill68.268.2
+ Other Intangibles0.20.2
+ Intangibles under Development6.66.6
+ Other Non-current Financial Assets19.519.5
Non-current Financial Assets19.519.5
+ Deferred Tax Assets0.50.5
+ Other Non-current Assets53.553.5
Total Non-current Assets550.9550.9
Current Assets
+ Inventories216.0216.0
+ Trade Receivables227.5227.5
+ Cash & Cash Equivalents26.726.7
+ Other Bank Balances87.987.9
+ Short-term Loans0.30.3
+ Other Current Financial Assets5.35.3
Current Financial Assets347.8347.8
+ Other Current Assets60.160.1
Total Current Assets624.0624.0
Total Assets1,174.91,174.9
Equity
+ Equity Share Capital11.311.3
+ Other Equity / Reserves872.0872.0
Equity — Owners of Parent883.3883.3
+ Minority Interest14.814.8
Total Equity898.1898.1
Liabilities
+ Borrowings — Non-current34.334.3
+ Other Non-current Financial Liab29.829.8
Non-current Financial Liabilities64.064.0
+ Provisions — Non-current0.00.0
+ Deferred Tax Liabilities9.49.4
+ Other Non-current Liabilities1.31.3
Non-current Liabilities74.874.8
+ Borrowings — Current114.0114.0
+ Trade Payables68.468.4
+ Other Current Financial Liab8.08.0
Current Financial Liabilities190.4190.4
+ Provisions — Current1.21.2
+ Current Tax Liabilities1.01.0
+ Other Current Liabilities9.39.3
Current Liabilities202.0202.0
Total Liabilities276.8276.8
Total Equity & Liabilities1,174.91,174.9
Trade Payables — MSME split
+ Dues to Micro & Small — Current1.31.3
+ Dues to Other Creditors — Current67.167.1
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.